Impact and Cost-Effectiveness of Culture for Diagnosis of Tuberculosis in HIV-Infected Brazilian Adults
Open Access
- 29 December 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (12), e4057
- https://doi.org/10.1371/journal.pone.0004057
Abstract
Culture of Mycobacterium tuberculosis currently represents the closest “gold standard” for diagnosis of tuberculosis (TB), but operational data are scant on the impact and cost-effectiveness of TB culture for human immunodeficiency (HIV-) infected individuals in resource-limited settings. We recorded costs, laboratory results, and dates of initiating TB therapy in a centralized TB culture program for HIV-infected patients in Rio de Janeiro, Brazil, constructing a decision-analysis model to estimate the incremental cost-effectiveness of TB culture from the perspective of a public-sector TB control program. Of 217 TB suspects presenting between January 2006 and March 2008, 33 (15%) had culture-confirmed active tuberculosis; 23 (70%) were smear-negative. Among smear-negative, culture-positive patients, 6 (26%) began TB therapy before culture results were available, 11 (48%) began TB therapy after culture result availability, and 6 (26%) did not begin TB therapy within 180 days of presentation. The cost per negative culture was US$17.52 (solid media)–$23.50 (liquid media). Per 1,000 TB suspects and compared with smear alone, TB culture with solid media would avert an estimated eight TB deaths (95% simulation interval [SI]: 4, 15) and 37 disability-adjusted life years (DALYs) (95% SI: 13, 76), at a cost of $36 (95% SI: $25, $50) per TB suspect or $962 (95% SI: $469, $2642) per DALY averted. Replacing solid media with automated liquid culture would avert one further death (95% SI: −1, 4) and eight DALYs (95% SI: −4, 23) at $2751 per DALY (95% SI: $680, dominated). The cost-effectiveness of TB culture was more sensitive to characteristics of the existing TB diagnostic system than to the accuracy or cost of TB culture. TB culture is potentially effective and cost-effective for HIV-positive patients in resource-constrained settings. Reliable transmission of culture results to patients and integration with existing systems are essential.Keywords
This publication has 27 references indexed in Scilit:
- Impact of enhanced tuberculosis diagnosis in South Africa: A mathematical model of expanded culture and drug susceptibility testingProceedings of the National Academy of Sciences of the United States of America, 2008
- Performance assessment of the Capilia TB assay and the BD ProbeTec ET system for rapid culture confirmation of Mycobacterium tuberculosisDiagnostic Microbiology and Infectious Disease, 2007
- Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003Thorax, 2007
- Access to diagnostics in support of HIV/AIDS and tuberculosis treatment in developing countriesAIDS, 2007
- Facing the Crisis: Improving the Diagnosis of Tuberculosis in the HIV EraThe Journal of Infectious Diseases, 2007
- Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy interventionClinical Trials, 2007
- Reducing the global burden of tuberculosis: the contribution of improved diagnosticsNature, 2006
- Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TBNew England Journal of Medicine, 2006
- The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical modelAIDS, 2006
- The development of clinical tuberculosis following infection with tubercle bacilliTubercle, 1982